» Articles » PMID: 30504773

Cardiac Specific PRMT1 Ablation Causes Heart Failure Through CaMKII Dysregulation

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Dec 4
PMID 30504773
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Dysregulation of Ca/calmodulin-dependent protein kinase (CaMK)II is closely linked with myocardial hypertrophy and heart failure. However, the mechanisms that regulate CaMKII activity are incompletely understood. Here we show that protein arginine methyltransferase 1 (PRMT1) is essential for preventing cardiac CaMKII hyperactivation. Mice null for cardiac PRMT1 exhibit a rapid progression to dilated cardiomyopathy and heart failure within 2 months, accompanied by cardiomyocyte hypertrophy and fibrosis. Consistently, PRMT1 is downregulated in heart failure patients. PRMT1 depletion in isolated cardiomyocytes evokes hypertrophic responses with elevated remodeling gene expression, while PRMT1 overexpression protects against pathological responses to neurohormones. The level of active CaMKII is significantly elevated in PRMT1-deficient hearts or cardiomyocytes. PRMT1 interacts with and methylates CaMKII at arginine residues 9 and 275, leading to its inhibition. Accordingly, pharmacological inhibition of CaMKII restores contractile function in PRMT1-deficient mice. Thus, our data suggest that PRMT1 is a critical regulator of CaMKII to maintain cardiac function.

Citing Articles

Genetic variation in RYR1 is associated with heart failure progression and mortality in a diverse patient population.

Guerra L, Lteif C, Huang Y, Flohr R, Nogueira A, Gawronski B Front Cardiovasc Med. 2025; 12:1529114.

PMID: 40060969 PMC: 11885062. DOI: 10.3389/fcvm.2025.1529114.


Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease.

Zhang Y, Wei S, Jin E, Jo Y, Oh C, Bae G Diabetes Metab J. 2024; 48(4):487-502.

PMID: 39043443 PMC: 11307121. DOI: 10.4093/dmj.2023.0362.


Metabolic changes contribute to maladaptive right ventricular hypertrophy in pulmonary hypertension beyond pressure overload: an integrative imaging and omics investigation.

Garcia-Lunar I, Jorge I, Saiz J, Solanes N, Dantas A, Rodriguez-Arias J Basic Res Cardiol. 2024; 119(3):419-433.

PMID: 38536505 PMC: 11143050. DOI: 10.1007/s00395-024-01041-5.


Increased GIRK channel activity prevents arrhythmia in mice with heart failure by enhancing ventricular repolarization.

An X, Cho H Sci Rep. 2023; 13(1):22479.

PMID: 38110503 PMC: 10728207. DOI: 10.1038/s41598-023-50088-2.


miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathway.

Cai S, Chang J, Su M, Wei Y, Sun H, Chen C Cell Mol Life Sci. 2023; 80(12):359.

PMID: 37951845 PMC: 10640488. DOI: 10.1007/s00018-023-04987-2.


References
1.
Yang Z, Bowles N, Scherer S, Taylor M, Kearney D, Ge S . Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res. 2006; 99(6):646-55. DOI: 10.1161/01.RES.0000241482.19382.c6. View

2.
Choi D, Oh K, Han H, Yoon Y, Jung C, Kim S . Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner. Hepatology. 2012; 56(4):1546-56. DOI: 10.1002/hep.25809. View

3.
Westenbrink B, Edwards A, McCulloch A, Brown J . The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias. Expert Opin Ther Targets. 2013; 17(8):889-903. PMC: 5551677. DOI: 10.1517/14728222.2013.809064. View

4.
McKinsey T, Zhang C, Olson E . Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A. 2000; 97(26):14400-5. PMC: 18930. DOI: 10.1073/pnas.260501497. View

5.
Lu Y, Ma W, Li Z, Lu J, Wang X . The interplay between p16 serine phosphorylation and arginine methylation determines its function in modulating cellular apoptosis and senescence. Sci Rep. 2017; 7:41390. PMC: 5264599. DOI: 10.1038/srep41390. View